Proteon Therapeutics Inc (PRTO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Proteon Therapeutics Inc (PRTO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9780
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its product candidate includes vonapanitase, an investigational drug intended to treat vessel injury that leads to blood vessel blockage and reduced blood flow. Proteon Therapeutics’ vonapanitase is under Phase 3 clinical study in hemodialysis vascular access. The company’s product is also studied in patients with peripheral arterial disease. It owns and operates research facilities in Kansas City, Missouri. Proteon Therapeutics is headquartered in Waltham, Massachusetts, the US.

Proteon Therapeutics Inc (PRTO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Proteon Therapeutics Raises USD22 Million in Venture Financing 10
Proteon Therapeutics Raises USD45 Million in Series D Financing 11
Proteon Therapeutics Raises US$4.3 Million In Venture Financing 13
Equity Offering 14
Proteon Therapeutics Raises USD22 Million in Private Placement of Shares 14
Proteon Therapeutics Raises USD0.2 Million in Public Offering of Shares 16
Proteon Therapeutics Completes Underwriters Exercise of Over-Allotment Option of IPO for USD70 Million 17
Debt Offering 19
Proteon Therapeutics Raises USD4.3 Million in Public Offering of Notes 19
Proteon Therapeutics Inc – Key Competitors 20
Proteon Therapeutics Inc – Key Employees 21
Proteon Therapeutics Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Nov 07, 2018: Proteon Therapeutics announces third quarter 2018 financial results 23
Aug 07, 2018: Proteon Therapeutics Announces Second Quarter 2018 Financial Results 25
May 09, 2018: Proteon Therapeutics Announces First Quarter 2018 Financial Results 27
Mar 14, 2018: Proteon Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results 29
Nov 07, 2017: Proteon Therapeutics Announces Third Quarter 2017 Financial Results 31
Aug 07, 2017: Proteon Therapeutics Announces Second Quarter 2017 Financial Results 33
May 10, 2017: Proteon Therapeutics Announces First Quarter 2017 Financial Results 35
May 10, 2017: Proteon Therapeutics Q1 net loss decreases 37
Mar 16, 2017: Proteon Therapeutics annual net loss increases 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteon Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Proteon Therapeutics Raises USD22 Million in Venture Financing 10
Proteon Therapeutics Raises USD45 Million in Series D Financing 11
Proteon Therapeutics Raises US$4.3 Million In Venture Financing 13
Proteon Therapeutics Raises USD22 Million in Private Placement of Shares 14
Proteon Therapeutics Raises USD0.2 Million in Public Offering of Shares 16
Proteon Therapeutics Completes Underwriters Exercise of Over-Allotment Option of IPO for USD70 Million 17
Proteon Therapeutics Raises USD4.3 Million in Public Offering of Notes 19
Proteon Therapeutics Inc, Key Competitors 20
Proteon Therapeutics Inc, Key Employees 21
Proteon Therapeutics Inc, Subsidiaries 22

List of Figures
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Proteon Therapeutics Inc (PRTO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Heartland Financial USA, Inc.:企業のM&A・事業提携・投資動向
    Heartland Financial USA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Heartland Financial USA, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Datron World Communications, Inc.:企業の戦略・SWOT・財務分析
    Datron World Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Datron World Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Fabasoft Ag:企業の戦略・SWOT・財務分析
    Fabasoft Ag - Strategy, SWOT and Corporate Finance Report Summary Fabasoft Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Gould Paper Corporation, Inc.:企業の戦略・SWOT・財務情報
    Gould Paper Corporation, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gould Paper Corporation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Fidelity Life Assurance of Zimbabwe Ltd:企業の戦略・SWOT・財務情報
    Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Ichor Holdings Ltd (ICHR):企業の財務・戦略的SWOT分析
    Ichor Holdings Ltd (ICHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aerpio Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aerpio Therapeutics Inc (Aerpio) is a biopharmaceutical company that develops novel monoclonal antibodies and small molecules. The company’s programs include a Tie-2 activator for diabetic macular edema and a hypoxia-inducible factor stabilizer for the treatment of inflammatory bowel disease …
  • Lee Enterprises, Incorporated:企業の戦略・SWOT・財務情報
    Lee Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Lee Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hilton Worldwide Holdings Inc:戦略・SWOT・企業財務分析
    Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • TiGenix NV (TIG):企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Cooper-Standard Holdings Inc.
    Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Per Aarsleff Holding AS (PAAL B):企業の財務・戦略的SWOT分析
    Per Aarsleff Holding AS (PAAL B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Colt Group Ltd:企業の戦略的SWOT分析
    Colt Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • MilliporeSigma:企業の戦略的SWOT分析
    MilliporeSigma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • HealthTronics Inc:医療機器:M&Aディール及び事業提携情報
    Summary HealthTronics Inc (HealthTronics), a subsidiary of Altaris Capital Partners, LLC, carries out manufacturing, marketing and distribution of lithotripters, cryoblation devices and nerve monitoring equipment. The various products and services offered by the company include lithotripsy services, …
  • Titan Company Ltd (TITAN):企業の財務・戦略的SWOT分析
    Summary Titan Company Ltd (Titan) is a retailing company. Its product portfolio includes eyewear, watches and accessories; jewelry; and fashion accessories. The company offers jewelry products comprising of pendant, chain, gold coin, earrings, finger ring and neckwear. Titan offers eyewear products …
  • Agilvax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung …
  • MediciNova Inc (MNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary MediciNova Inc (MediciNova) focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs for the treatment of fibrotic diseases; neurological disorders; and …
  • Banco del Pichincha C.A.:企業の戦略・SWOT・財務情報
    Banco del Pichincha C.A. - Strategy, SWOT and Corporate Finance Report Summary Banco del Pichincha C.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆